BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
82.00
+30.00 (57.69%)
Jul 4, 2025, 3:30 PM JST

TYO:4594 Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2018 FY 2017
Period Ending
Mar '25 Mar '24 Mar '18 Mar '17
Cash & Equivalents
810.471,0576,5284,950
Cash & Short-Term Investments
810.471,0576,5284,950
Cash Growth
-23.35%-83.80%31.88%-
Accounts Receivable
1.150.017754
Other Receivables
63.5337.98--
Receivables
64.6837.997754
Inventory
--2742
Other Current Assets
196.1785.62268193
Total Current Assets
1,0711,1816,9005,239
Property, Plant & Equipment
--266115
Long-Term Investments
--5539
Other Intangible Assets
--1313
Other Long-Term Assets
49.349.312
Total Assets
1,1211,2307,2355,408
Accounts Payable
0.040.02822
Accrued Expenses
3.286.09--
Short-Term Debt
25112.5--
Current Income Taxes Payable
17.0712.82198113
Other Current Liabilities
86.2859.592326
Total Current Liabilities
131.66191.01229161
Long-Term Deferred Tax Liabilities
--44
Other Long-Term Liabilities
22.7422.652118
Total Liabilities
195.63251.27285208
Common Stock
1,200650.665,4193,774
Additional Paid-In Capital
3,5082,9595,4033,757
Retained Earnings
-3,805-2,654-3,929-2,352
Treasury Stock
-0---
Comprehensive Income & Other
21.5822.855720
Total Common Equity
924.99978.996,9505,199
Minority Interest
---1
Shareholders' Equity
924.99978.996,9505,200
Total Liabilities & Equity
1,1211,2307,2355,408
Total Debt
25112.5--
Net Cash (Debt)
785.47944.866,5284,950
Net Cash Growth
-16.87%-85.53%31.88%-
Net Cash Per Share
9.6414.73170.73145.52
Filing Date Shares Outstanding
90.4964.1641.8637.22
Total Common Shares Outstanding
90.4964.1641.8437.22
Working Capital
939.65989.956,6715,078
Book Value Per Share
10.2215.26166.13139.69
Tangible Book Value
924.99978.996,9375,186
Tangible Book Value Per Share
10.2215.26165.82139.34
Updated Feb 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.